Literature DB >> 30864155

The combination of an inclusive novel agent treatment strategy, pre-emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients.

Nadishani Ediriwickrama1, Titi Oyebamiji1, Sreetharan Munisamy1, Paula Garland1, Kirsty Cuthill1, Reuben Benjamin1, M Mansour Ceesay1, Stella Bowcock1.   

Abstract

Entities:  

Keywords:  dose reduction; elderly; myeloma; novel agent; overall survival

Mesh:

Substances:

Year:  2019        PMID: 30864155     DOI: 10.1111/bjh.15848

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.

Authors:  Laurence Huynh; Rudy Birsen; Lucie Mora; Anne-Laure Couderc; Nathalie Mitha; Anaïs Farcet; Amale Chebib; Pascal Chaibi
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.